Editor-in-Chief
Janice M. Reichert, Ph.D.

Dr. Reichert has studied innovation in the pharmaceutical and biotechnology industries at the Tufts Center for the Study of Drug Development since 1999. Her work focuses on strategic analyses of candidate and approved products, including clinical development and approval times, and probabilities of approval success for new therapeutics and vaccines. Dr. Reichert has published extensively on these topics, and she has presented her research results as an invited speaker at conferences in the United States, Europe, Canada, and China.

Dr. Reichert is Vice President of the board of directors of The Antibody Society and a member of the board of directors of the Peptide Therapeutics Foundation. In addition, she regularly provides input to various government, non-profit, and industry organizations, including the National Institutes of Health.

Dr. Reichert received her Ph.D. in organic chemistry from the University of Pennsylvania and her postdoctoral training as a National Institutes of Health Research Fellow at Harvard Medical School. Before joining the Tufts Center for the Study of Drug Development, Dr. Reichert performed drug discovery research and preclinical development at several companies in the Boston area.

Associate Editor
Alain Beck, Ph.D.
 Centre d'immunologie Pierre Fabre (CIPF), St. Julien-en-Genevois, France

Editorial Board
Gregory P. Adams, Ph.D.
 Fox Chase Cancer Center, Philadelphia, PA USA
S. Robert Adamson, Ph.D.
 Wyeth Biotech, Madison, NJ USA
Nasimul Ahsan, M.D, M.B.A., FACP
 Mayo Clinic Transplant Center, Jacksonville, FL USA
Ashraf Amanullah Ph.D.
 Genentech, Inc., Oceanside, CA USA
Laurent P. Audoly, Ph.D.
 Merck BioVentures, Rahway, NJ USA
Joseph P. Balthasar, Ph.D.
 State University of New York at Buffalo, Buffalo, NY USA
Detlev Biniszkiewicz, Ph.D.
 Novartis Institutes for BioMedical Research, Cambridge, MA USA
Sally Bolmer, Ph.D., RAC
 Human Genome Sciences, Inc., Rockville, MD USA
Pavel V. Bondarenko, Ph.D.
 Amgen, Thousand Oaks, CA USA
Arindam Bose Ph.D.
 Pfizer Global R&D, New London, CT USA
Andrew Bradbury, M.B., Ph.D.
 Los Alamos National Laboratory, Los Alamos, NM, USA
John C. Byrd, M.D.
 The Ohio State University, Columbus, OH USA
Paul J. Carter, Ph.D.
 Genentech, Inc., San Francisco, CA USA
Michel Chartrain, Ph.D.
 Merck & Co., Inc., Rahway, NJ USA
Vijay K. Chaudhary, M.Sc., Ph.D.
 University of Delhi South Campus, New Delhi, India
Mike Clark, Ph.D.
 Cambridge University, Cambridge, UK
Raphael Clynes, M.D., Ph.D.
 Columbia University, New York, NY USA
Nathalie Corvaia, Ph.D.
 Centre d'Immunologie Pierre Fabre, St Julien-en-Genevois, France
Graeme Currie, Ph.D.
 PDL Biopharma, Redwood City, CA USA
John R. Desjarlais, Ph.D.
 Xencor, Inc., Monrovia, CA USA
Dimiter S. Dimitrov, Ph.D.
 NCI, NIH, Frederick, MD USA
Donald L. Drakeman, J.D., Ph.D.
 Advent Venture Partners, Princeton, NJ USA
Stefan Dübel, Ph.D.
 Technical University of Braunschweig, Braunschweig, Germany
Martin Glennie, Ph.D.
 University of Southampton, Southampton, UK
David Glover, M.A., M.B.
 MedCell Bioscience, Ltd., Cambridge, UK
Iqbal S. Grewal Ph.D., FRCPath
 Seattle Genetics, Inc., Bothell, WA USA
Yajun Guo, M.D., Ph.D.
 Second Military Medical University, Shanghai, China
Sherif Hanala, M.B.A.
 Global BioFocus LLP, San Francisco, CA USA
Raffit Hassan, M.D.
 NCI, NIH, Bethesda, MD USA
P. Mark Hogarth, Ph.D.
 Burnet Institute, Heidelberg, Victoria Australia
Hennie R. Hoogenboom, Ph.D.
 BioQuest BV, Eindohoven Area, Netherlands
James S. Huston, Ph.D.
 EMD Serono - Lexigen Research Center, Billerica, MA USA
Roy Jefferis, Ph.D.
 University of Birmingham, Birmingham, UK
Dennis M. Kraichely, Ph.D.
 Centocor R&D, Inc., Radnor, PA USA
Gaurav Laroia, Ph.D.
 Merck & Co., Inc., Whitehouse Station, NJ USA
Marie-Paule Lefranc, Ph.D.
 IMGT, CNRS, Université Montpellier 2, Montpellier, France
Nils Lonberg, Ph.D.
 Bristol-Myers Sqibb/Medarex
Henry Lowman, Ph.D.
 NGM Biopharmaceuticals, Inc., South San Francisco, CA USA
James D. Marks, M.D., Ph.D.
 University of California, San Francisco, San Francisco, CA USA
John L. Marquardt, Jr., J.D., M.B.A., Ph.D.
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington D.C. USA
R.A. Mashelkar, Ph.D., F.R.S.
 National Chemical Laboratory, Pune, India
Richard Mason, BSc, MBBS, MRCP, MBA
 BTG International Ltd., London UK
John McCafferty, Ph.D.
 University of Cambridge, Cambrige UK
Jan ter Meulen, M.D.
 Merck Research Laboratories, West Point, PA USA
Sherie Morrison, Ph.D.
 University of California, Los Angeles, Los Angeles, CA USA
Jan Mueller-Berghaus, M.D.
 Paul-Ehrlich-Institute, Langen, Germany
Bilikallahalli K. Muralidhara, Ph.D.
 Pfizer R&D-Global Biologics, St. Louis, MO USA
Dario Neri, Ph.D.
 Swiss Federal Institute of Technology, Zurich, Switzerland
Jane Osbourn, Ph.D.
 MedImmune, Inc. Cambridge, UK
Gilles Paintaud, Ph.D. M.D.
 François Rabelais University and CNRS, Tours, France
Paul W.H.I. Parren, Ph.D.
 Genmab, Utrecht, The Netherlands
Ira Pastan, M.D.
 NCI, NIH, Bethesda, MD USA
Andre Pelegrin, Ph.D.
 INSERM, Montpellier, France
Andreas Plückthun, Ph.D.
 Universitaet Zurich, Zurich, Switzerland
Leonard Presta, Ph.D.
 Schering-Plough Biopharma, Palo Alto, CA USA
Vijay Ramakrishnan Ph.D.
 Pikamab, Inc., Menlo Park, CA USA
Mitsuo Satoh, Ph.D.
 Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan
Christian K. Schneider, M.D.
 Paul-Ehrlich-Institut (PEI), Langen, Germany, European Medicines Agency (EMEA), London, UK
Jamie Kathleen Scott, M.D., Ph.D.
 Simon Fraser University, Burnaby, BC Canada
Marjorie A. Shapiro, Ph.D.
 Center for Drug Evaluation and Research, US Food and Drug Administration
Kiran Mazumdar Shaw
 Biocon, Ltd., Bangalore, India
Sachdev Sidhu, Ph.D.
 University of Toronto, Toronto, ON Canada
Arne Skerra, Ph.D.
 Technische Universitaet Muenchen, Freising-Weihenstephan, Germany
Jean-Luc Teillaud, Dr.Sc.
 Centre de Recherche des Cordeliers/INSERM, France
Pablo Umana, Ph.D.
 Glycart Biotechnology AG (Roche Group), Zurich, Switzerland
E. Sally Ward, Ph.D.
 University of Texas, Southwestern, Dallas, TX USA
Herve Watier, M.D., Ph.D.
 Universite Framcpos-Rabelis de Tours and CNRS, Tours, France
Louis M. Weiner, M.D.
 Georgetown University Medical Center, Washington D.C, USA
Jan van de Winkel, Ph.D.
 Genmab, Utrecht, The Netherlands
Sir Gregory Winter, C.B.E, F.R.S.
 MRC Laboratory of Molecular Biology, Cambridge, UK
K. Dane Wittrup, Ph.D.
 Massachusetts Institute of Technology, Cambridge, MA USA
Clive R. Wood
 Bayer Schering Pharma AG, Wuppertal, Germany
Jenny M. Woof, Ph.D.
 University of Dundee Medical School, Dundee, UK
Herren Wu, Ph.D.
 MedImmune, Inc., Gaithersburg, MD USA
Thierry Wurch, Ph.D.
 Institut de Recherche Pierre Fabre, St. Julien-en-Genevois, France
Bodi Zhang, M.D.
 Tufts University, Boston, MA USA
Advertisements